Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-10-16 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关于对外投资设立全资子公司并取得营业执照的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Ningbo Xinzhi Biotechnology Co., Ltd. regarding the establishment of a wholly-owned subsidiary and the acquisition of its business license. It details the investment amount, the nature of the investment, and confirms that it does not constitute a major asset restructuring or related party transaction. The document is relatively short (1558 characters) and focuses on a corporate action related to capital investment and subsidiary formation. It does not contain financial statements or detailed financial performance data. This fits the category of a Capital/Financing Update (CAP), as it reports on the company's financing activity and capital structure changes through the establishment of a new subsidiary.
2025-10-16 Chinese
中信证券股份有限公司关于宁波新芝生物科技股份有限公司一致行动人协议到期终止及部分股东重新签订一致行动人协议暨实际控制人及其一致行动人变更的核查意见
Regulatory Filings Classification · 91% confidence The document is a formal sponsor opinion (“核查意见”) regarding the termination and re-execution of a concerted action agreement and consequent change in the company’s actual controller. It does not contain financial statements or quarterly/annual results, nor is it an internal audit, dividend notice, or share transaction report. It is a regulatory disclosure required by the Beijing Stock Exchange and fits the catch-all “Regulatory Filings” category rather than a dedicated shareholding or M&A form. Therefore, it should be classified as RNS.
2025-10-13 Chinese
简式权益变动报告书（朱佳军）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in equity interests of an information disclosure obligor (朱佳军) in 宁波新芝生物科技股份有限公司. The document includes detailed information about the nature of the equity change, the reason (expiration of a concerted action agreement), the shareholding percentages before and after the change, and confirms no actual change in share quantity but a change in the classification of shares held due to the end of the agreement. It also references relevant Chinese securities laws and disclosure rules. This type of document is a notification of changes in significant share ownership or related equity interests, fitting the definition of a Major Shareholding Notification (MRQ). The document is substantive and not merely an announcement or certification, and it is not a full financial report or other category. Therefore, the correct classification is MRQ with high confidence.
2025-10-13 Chinese
详式权益变动报告书（周芳、肖长锦、肖艺）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "详式权益变动报告书" which translates to a "Detailed Equity Change Report." It discusses changes in shareholding and control relationships among shareholders, specifically the expiration and renewal of a "一致行动人协议" (acting-in-concert agreement) among shareholders. The document includes detailed information about the shareholders, their shareholdings, the nature of the equity change, and the impact on the company's control structure. It references compliance with securities laws and disclosure obligations. There is no indication of financial statements, audit opinions, earnings data, or other financial report content. The document is a formal disclosure of changes in significant share ownership and control, fitting the definition of a Major Shareholding Notification (MRQ).
2025-10-13 Chinese
北京炜衡（宁波）律师事务所关于宁波新芝生物科技股份有限公司实际控制人变更的法律意见书
Regulatory Filings Classification · 75% confidence The document is a legal opinion letter issued by a law firm regarding the change of the company’s actual controlling shareholders. It is not an annual or interim financial report, earnings release, management discussion, call transcript, M&A proxy, board change notice, or any other specific category. It serves as a compliance/legal opinion rather than the report itself, and thus falls into the general Regulatory Filings (RNS) category as a miscellaneous regulatory/compliance document.
2025-10-13 Chinese
一致行动人协议到期终止及部分股东重新签订一致行动人协议暨实际控制人及其一致行动人变更公告
Major Shareholding Notification Classification · 95% confidence The document is an official announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the expiration and termination of a previous concerted action agreement among shareholders and the signing of a new concerted action agreement. It details the change in actual controllers and concerted actors, including shareholding percentages and the impact on the company. The document includes legal opinions, shareholder information, and compliance with relevant securities laws and regulations. There is no financial data, earnings information, or report publication notice. The content focuses on changes in actual control and shareholder agreements, which aligns with announcements about changes in significant share ownership or control. Therefore, the document fits best under the category of Major Shareholding Notification (MRQ).
2025-10-13 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.